Coverage summary
Aardvark Labs Capital Research has covered The Procter & Gamble Company (PG) since October 25, 2025. The company is in the Consumer Defensive sector. This page lists 5 reports: 5 earnings recaps.
The latest is the Q1 FY27 Earnings Recap, published October 26, 2026. That report moved the rating from Underperform to Hold. The rating has changed twice since coverage began.
Translations: 4 in Chinese.
The Excel model for PG holds 20 quarters and 5 fiscal years of history and 8 quarters and 5 fiscal years of projections. It was last updated September 27, 2026.
Rating history
All PG reports
Recap: Q1 FY27
Volume Comes Back Early: A 4% Organic Quarter Trips Our Upgrade Trigger, While a Bigger Oil Bill and a 23x Multiple Cap PG at Hold
Recap: Q4 FY26
The Turn Stalls: Organic Rounds to Zero, Share Slips to an Eight-Year Low, and the First FY27 Guide Lands Under the Street
Recap: Q3 FY26
The Ship Turns Just as an Oil Shock Blows In: P&G's Operational Inflection Arrives Alongside a ~$1B Middle East Cost Overhang
Recap: Q2 FY26
P&G's Softest Quarter Lands Mid-Year: Flat Organic Sales Put the Entire H2 Reacceleration Story on the Clock
Recap: Q1 FY26
P&G Banks $500 Million of Cost Relief and Guides None of It: The Beat Funds a Share War It Is Currently Losing